The short answer is no — and the distinction matters when you're trying to understand what you're being offered, what it will do, and whether it's appropriate for your goals.
Both are injectable products. Both often contain hyaluronic acid. But they're designed to do different things, and using one when you wanted the other produces a different result.
What a Traditional Dermal Filler Is Designed to Do
Traditional HA fillers — products like Juvederm, Restylane, and Sculptra in their various formulations — are designed to add volume and structural support. They're engineered to have high viscosity (thickness) and, in the case of structural fillers, high G prime (stiffness), which allows them to hold shape in tissue, lift sagging areas, and fill depressions.
When a provider places a cheek filler or treats a nasolabial fold, they're using a product that is meant to stay where it's placed, provide lift or projection, and maintain that effect for months to over a year.
What a Skin Booster Is Designed to Do
A skin booster — the original and most widely known is Restylane Skinboosters, but the category now includes products like Juvederm Volite, RHA Redensity, and the increasingly prominent Skinvive by Juvederm — is a different formulation of HA designed to hydrate and improve skin quality rather than add volume or structure.
These products are typically lower viscosity, with smaller HA molecules that integrate into the dermis rather than sitting within it as a structural support. The intended effect is:
•Increased skin hydration
•Improved skin elasticity and smoothness
•Subtle glow and texture improvement
•Reduction of fine-line appearance through hydration rather than filling
Skinvive in particular has received significant attention since its FDA approval for cheek skin quality improvement. It's injected in a micro-droplet pattern across the skin rather than deposited in deeper tissue layers as a filler would be. The result is a diffuse skin quality improvement rather than a structural change.
Why the Distinction Matters for Patients
A patient who wants to plump their lips or address volume loss in the midface needs a structural filler — a skin booster used in that context will not produce the effect they're looking for. The products aren't interchangeable for structural applications.
Conversely, a patient whose primary concern is skin quality — texture, hydration, that "glass skin" glow — may be well served by a skin booster without any structural filler at all.
The confusion arises because some providers offer both under the vague category of "filler." A thorough consultation should clarify which product is being recommended, why it's appropriate for your specific concern, and what the realistic outcome will be.
Skinvive: What the Evidence Actually Shows
Skinvive (JUVÉDERM SKINVIVE by ALLERGAN) received FDA approval specifically for improving the appearance of facial skin in the cheeks. Clinical trials showed improvement in skin smoothness, hydration, and overall appearance that patients rated positively at 24 weeks.
What Skinvive doesn't do: it doesn't lift, add structural volume, or address deep static lines. It's been positioned as a skin quality treatment rather than a volumizing one. Its results are subtle — patients describe looking "refreshed" or "more hydrated" rather than dramatically changed.
Duration is approximately 6 months in most patients before a maintenance treatment is warranted.
Polynucleotides: A Different Category Worth Knowing
Polynucleotides (PDRN) are a newer injectable in the aesthetic space that's gaining traction in the US after years of use in Europe and Asia. They're derived from salmon or trout DNA and work by stimulating cellular regeneration rather than adding volume or hydration directly.
Unlike HA-based skin boosters, polynucleotides don't hydrate by holding water molecules — they stimulate fibroblast activity and tissue repair, with the goal of improving skin quality through cellular biology rather than direct hydration. Early clinical evidence is positive for skin texture and tone improvement.
Polynucleotides are not currently FDA-approved for aesthetic use in the US as of mid-2026, though several products are in the regulatory pathway. They are available in the US at some practices as part of off-label use or under investigational protocols. Patients interested in this category should ask specifically about the regulatory status of any polynucleotide product being offered.
Questions to Ask at a Consultation
Before agreeing to any injectable treatment, it's reasonable to ask:
•Is this a structural filler or a skin quality treatment?
•What specific product are you recommending, and what is its FDA-approved indication?
•What results should I realistically expect, and what won't this product do?
•How does this compare to other options for my specific concern?
A provider who can explain these distinctions clearly and match their recommendation to your actual goal — rather than defaulting to whatever they have in stock or currently promote — is giving you the consultation you deserve.
This article is educational and does not constitute medical advice. Specific treatment recommendations should come from a licensed medical professional after assessment of your individual anatomy and concerns.
Looking for a injectables provider?